Notes
2011 values
Reference
Hornberger J, et al. Cost-effectiveness of gene-expression profiling for tumor-site origin. Value in Health 16: 46-56, No. 1, Jan 2013. Available from: URL: http://dx.doi.org/10.1016/j.jval.2012.09.005
Rights and permissions
About this article
Cite this article
GEP TOO testing not too costly to identify primary tumour. PharmacoEcon Outcomes News 671, 9 (2013). https://doi.org/10.1007/s40274-013-0144-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0144-9